While the West Virginia Legislature debated making insulin more affordable, one pharmaceutical company surprisingly stepped up. On March 1, Eli Lilly announced it would limit monthly patient out-of-pocket costs to $35 or less for its most common insulins: its non-branded insulin starting ...
by Martin Schram Two big blips of downright infuriating news flashed across our news screens last week. But both vanished quickly, swamped by the next gush of made-for-TV stories. No wonder most of us never noticed those big bad blips. Even our usual trusty watchdogs never barked. ...
“Companies are paying higher wages, spending more for materials and absorbing record freight costs, pushing up economic inflation gauges. They are also reporting some of their best profitability in years.” The above quote comes from the article “What Does Inflation Mean for American ...
by Kyle Herrig Americans paying more at the grocery store and gas pump are told that supply-chain issues related to the coronavirus pandemic and the Russian war against Ukraine are fully to blame. But, in truth, corporate executives are also exploiting these crises to make record ...